111 Announced Receipt Of Withdrawal Of Going Private Proposal
111 Announced Receipt Of Withdrawal Of Going Private Proposal
111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it has received a notice dated Feburary 27, 2024 on behalf of the consortium comprising Dr. Gang Yu, co-founder and co-chairman of the Company, Mr. Junling Liu, co-founder, co-chairman and chief executive officer of the Company and certain other investors (collectively, the "Consortium"), stating that the Consortium would withdraw its preliminary non-binding going private proposal dated September 9, 2022 and preliminary non-binding going private proposal dated October 29, 2022 (collectively, the "Proposals"). The Consortium will formally terminate further negotiation with the special committee of the Company's board of directors regarding the transactions as contemplated by the Proposals.
111, Inc.（“111” 或 “公司”）（納斯達克股票代碼：YI）是一家領先的科技型醫療保健平台公司，致力於以數字方式將中國患者與醫療保健服務聯繫起來。該公司今天宣佈，它已收到2024年2月27日代表該財團發出的通知，該財團由公司聯合創始人兼聯席董事長餘剛博士、公司聯合創始人、聯席董事長兼首席執行官劉俊嶺先生以及其他一些人組成投資者 (統稱 “財團”) 表示, 該集團將撤回其初步的非強制性聲明,2022年9月9日的具有約束力的私有化提案和2022年10月29日的初步非約束性私有化提案（統稱爲 “提案”）。該財團將正式終止與公司董事會特別委員會就提案所設想的交易進行的進一步談判。
譯文內容由第三人軟體翻譯。